DaVita Healthcare Partners, Inc. is one of the largest kidney care companies in the United States, offering services such as hemodialysis, in-center nocturnal dialysis, peritoneal dialysis, home dialysis, chronic kidney disease education, and renal diet assistance.
DaVita was founded in 1994 as Total Renal Care (TRC), a dialysis company.
In 1999 the company was on the brink of bankruptcy. Kent Thiry joined the company as CEO and renamed it DaVita, which is Italian for giving life.
In 2004 DaVita merged with Gambro’s U.S.-based clinics which nearly doubled the number of DaVita’s outpatient facilities, combining DaVita’s 664 clinics with Gambro’s 565 clinics.
Today DaVita operates or provides administrative services through a network of 2,074 outpatient dialysis centers in the United States and 73 facilities in a further 10 countries.
DaVita is publicly traded on the New York Stock Exchange under the symbol DVA, is a member of the S&P 500, is #311 in the Fortune 500, has 57,400 employees, and $11.76 billion in revenue in 2013.